| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Experimental Studies |
Department of Internal Medicine, University of Ferrara (A.S.), Ferrara; the Division of Endocrinology and Metabolic Diseases, University of Verona (E.B., R.B.), Verona; and the Department of Internal Medicine, University of Catania (P.C.), Catania, Italy; and the Diabetes Division, University of Texas Health Science Center (R.A.D.), San Antonio, Texas 78226
Address all correspondence and requests for reprints to: Anna Solini, M.D., Department of Internal Medicine II, University of Ferrara, Via Savonarola 9, I-44100 Ferrara, Italy; or to: Ralph A. DeFronzo, M.D., Diabetes Division, Department of Internal Medicine, University of Texas Health Science Center, 7703 Floyd Curl Drive, San Antonio, Texas 78226.
It is controversial whether metabolic disorders of human obesity include protein metabolism. Even less information is available concerning the effect of fat distribution on protein metabolism. Therefore, a comprehensive evaluation of glucose, lipid, and protein metabolism was performed in 11 obese nondiabetic and 9 normal women whose body composition and regional fat distribution were determined. [1-14C]Leucine and [3-3H]glucose were infused in the postabsorptive state and during an euglycemic hyperinsulinemic (3540 µU/mL) clamp combined with indirect calorimetry for assessment of leucine flux, oxidation, and nonoxidative disposal, glucose turnover and oxidation, and lipid oxidation. Fat-free mass (FFM) was estimated by a bolus of 3H2O. Subcutaneous abdominal and visceral adipose tissues were determined by nuclear magnetic resonance imaging. During the clamp, obese women had lower glucose turnover (4.51 ± 0.41 vs. 6.63 ± 0.40 mg/min·kg FFM; P < 0.05), with a defect in both oxidation (3.27 ± 0.22 vs. 3.89 ± 0.21) and nonoxidative disposal (1.24 ± 0.27 vs. 2.74 ± 0.41; P < 0.005), whereas lipid oxidation was higher during the clamp (0.49 ± 0.15 vs. 0.17 ± 0.09 mg/min·kg FFM). There was no difference in leucine flux (basal, 2.23 ± 0.17 vs. 2.30 ± 0.29; clamp, 2.06 ± 0.19 vs. 2.10 ± 0.24 µmol/min·kg FFM), oxidation (basal, 0.37 ± 0.04 vs. 0.36 ± 0.05; clamp, 0.34 ± 0.04 vs. 0.39 ± 0.06) and nonoxidative leucine disposal (basal, 1.86 ± 0.17 vs. 1.94 ± 0.26; clamp, 1.72 ± 0.20 vs. 1.71 ± 0.19) in the two groups. In obese women, basal leucine oxidation was directly related with glucose oxidation and inversely to lipid oxidation (both P < 0.05), whereas visceral adipose tissue was inversely related to leucine flux both in the basal state and during the clamp (P < 0.05). In conclusion, in human obesity, 1) rates of protein metabolism in the basal state and in the range of insulin concentrations encountered after a meal are normal; 2) protein oxidation is positively related to glucose oxidation and negatively related to lipid oxidation; and 3) visceral adipose tissue is inversely related to all parameters of protein metabolism.
This article has been cited by other articles:
![]() |
P. She, C. Van Horn, T. Reid, S. M. Hutson, R. N. Cooney, and C. J. Lynch Obesity-related elevations in plasma leucine are associated with alterations in enzymes involved in branched-chain amino acid metabolism Am J Physiol Endocrinol Metab, December 1, 2007; 293(6): E1552 - E1563. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Gibney, M.-L. Healy, and P. H. Sonksen The Growth Hormone/Insulin-Like Growth Factor-I Axis in Exercise and Sport Endocr. Rev., October 1, 2007; 28(6): 603 - 624. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Burt, J. Gibney, and K. K. Y. Ho Protein metabolism in glucocorticoid excess: study in Cushing's syndrome and the effect of treatment Am J Physiol Endocrinol Metab, May 1, 2007; 292(5): E1426 - E1432. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Bell, E. Volpi, S. Fujita, J. G. Cadenas, M. Sheffield-Moore, and B. B. Rasmussen Skeletal Muscle Protein Anabolic Response to Increased Energy and Insulin Is Preserved in Poorly Controlled Type 2 Diabetes J. Nutr., May 1, 2006; 136(5): 1249 - 1255. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Chevalier, E. B Marliss, J. A Morais, M. Lamarche, and R. Gougeon Whole-body protein anabolic response is resistant to the action of insulin in obese women Am. J. Clinical Nutrition, August 1, 2005; 82(2): 355 - 365. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. de Simone, R. B Devereux, J. R Kizer, M. Chinali, J. N Bella, A. Oberman, D. W Kitzman, P. N Hopkins, D. Rao, and D. K Arnett Body composition and fat distribution influence systemic hemodynamics in the absence of obesity: the HyperGEN Study Am. J. Clinical Nutrition, April 1, 2005; 81(4): 757 - 761. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. You, A. S. Ryan, and B. J. Nicklas The Metabolic Syndrome in Obese Postmenopausal Women: Relationship to Body Composition, Visceral Fat, and Inflammation J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5517 - 5522. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Buijs, J. A. Romijn, J. Burggraaf, M. L. de Kam, A. F. Cohen, M. Frolich, F. Stellaard, A. E. Meinders, and H. Pijl Growth Hormone Blunts Protein Oxidation and Promotes Protein Turnover to a Similar Extent in Abdominally Obese and Normal-Weight Women J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5668 - 5674. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. L. Wajchenberg Subcutaneous and Visceral Adipose Tissue: Their Relation to the Metabolic Syndrome Endocr. Rev., December 1, 2000; 21(6): 697 - 738. [Abstract] [Full Text] |
||||
![]() |
M. J. Toth, A. Tchernof, C. J. Rosen, D. E. Matthews, and E. T. Poehlman Regulation of Protein Metabolism in Middle-Aged, Premenopausal Women: Roles of Adiposity and Estradiol J. Clin. Endocrinol. Metab., April 1, 2000; 85(4): 1382 - 1387. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |